BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Addetia K, Bhave NM, Tabit CE, Gomberg-Maitland M, Freed BH, Dill KE, Lang RM, Mor-Avi V, Patel AR. Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging 2014;7:115-24. [PMID: 24192452 DOI: 10.1161/CIRCIMAGING.113.000932] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Waxman AB, Farber HW. Using Clinical Trial End Points to Risk Stratify Patients with Pulmonary Arterial Hypertension. Circulation. 2015;132:2152-2161. [PMID: 26621638 DOI: 10.1161/circulationaha.114.012328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492. [PMID: 29540357 DOI: 10.1136/bmj.j5492] [Cited by in Crossref: 194] [Cited by in F6Publishing: 199] [Article Influence: 48.5] [Reference Citation Analysis]
3 Medvedofsky D, Mor-Avi V, Byku I, Singh A, Weinert L, Yamat M, Kruse E, Ciszek B, Nelson A, Otani K, Takeuchi M, Lang RM. Three-Dimensional Echocardiographic Automated Quantification of Left Heart Chamber Volumes Using an Adaptive Analytics Algorithm: Feasibility and Impact of Image Quality in Nonselected Patients. J Am Soc Echocardiogr 2017;30:879-85. [PMID: 28688857 DOI: 10.1016/j.echo.2017.05.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
4 Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD. Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives. Rheumatol Int 2018;38:949-58. [PMID: 29516170 DOI: 10.1007/s00296-018-4004-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
5 Ryan JJ, Huston J, Kutty S, Hatton ND, Bowman L, Tian L, Herr JE, Johri AM, Archer SL. Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol 2015;31:391-406. [PMID: 25840092 DOI: 10.1016/j.cjca.2015.01.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 13.3] [Reference Citation Analysis]
6 Wessels JN, de Man FS, Vonk Noordegraaf A. The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting? Eur Respir Rev 2020;29:200139. [PMID: 32620588 DOI: 10.1183/16000617.0139-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Raman S, Shafie AA, Abraham MT, Shim CK, Maling TH, Rajendran S, Cheong SC. Provider cost of treating oral potentially malignant disorders and oral cancer in Malaysian public hospitals. PLoS One 2021;16:e0251760. [PMID: 33984051 DOI: 10.1371/journal.pone.0251760] [Reference Citation Analysis]
8 Jiang R, Wang L, Yuan P, Zhao QH, Gong SG, He J, Qiu HL, Luo CJ, Zhang R, Shen T, Zhan MY, Jiang YM, Chen FD, Liu JM, Shen YQ. A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial. Front Med (Lausanne) 2022;9:835272. [PMID: 35449803 DOI: 10.3389/fmed.2022.835272] [Reference Citation Analysis]
9 Freed BH. REPAIRing What We Can't See: The Need for Imaging Endpoints in PAH Clinical Trials. JACC Cardiovasc Imaging 2021:S1936-878X(21)00683-5. [PMID: 34801460 DOI: 10.1016/j.jcmg.2021.09.006] [Reference Citation Analysis]
10 Lahm T, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM; American Thoracic Society Assembly on Pulmonary Circulation. Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2018;198:e15-43. [PMID: 30109950 DOI: 10.1164/rccm.201806-1160ST] [Cited by in Crossref: 95] [Cited by in F6Publishing: 48] [Article Influence: 31.7] [Reference Citation Analysis]
11 Narang A, Mor-Avi V, Prado A, Volpato V, Prater D, Tamborini G, Fusini L, Pepi M, Goyal N, Addetia K, Gonçalves A, Patel AR, Lang RM. Machine learning based automated dynamic quantification of left heart chamber volumes. Eur Heart J Cardiovasc Imaging 2019;20:541-9. [PMID: 30304500 DOI: 10.1093/ehjci/jey137] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
12 Freed BH, Collins JD, François CJ, Barker AJ, Cuttica MJ, Chesler NC, Markl M, Shah SJ. MR and CT Imaging for the Evaluation of Pulmonary Hypertension. JACC Cardiovasc Imaging 2016;9:715-32. [PMID: 27282439 DOI: 10.1016/j.jcmg.2015.12.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
13 Morris NR, Louis M, Strugnell W, Harris J, Lin A, Feenstra J, Seale H. Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH). BMC Pulm Med 2018;18:40. [PMID: 29490637 DOI: 10.1186/s12890-018-0586-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chia KS, Faux SG, Wong PK, Holloway C, Assareh H, McLachlan CS, Kotlyar E. Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol. BMJ Open 2017;7:e014037. [PMID: 28167746 DOI: 10.1136/bmjopen-2016-014037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
15 Argula RG, Ward C, Feghali-Bostwick C. Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH). Ther Clin Risk Manag 2019;15:1427-42. [PMID: 31853179 DOI: 10.2147/TCRM.S219024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Torbicki A. Right ventricle in pulmonary hypertension: echocardiography strikes back? Circ Cardiovasc Imaging 2015;8:e003518. [PMID: 26038433 DOI: 10.1161/CIRCIMAGING.115.003518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
17 Kowallick JT, Morton G, Lamata P, Jogiya R, Kutty S, Hasenfuß G, Lotz J, Chiribiri A, Nagel E, Schuster A. Quantitative assessment of left ventricular mechanical dyssynchrony using cine cardiovascular magnetic resonance imaging: Inter-study reproducibility. JRSM Cardiovasc Dis 2017;6:2048004017710142. [PMID: 28567282 DOI: 10.1177/2048004017710142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Kowallick JT, Morton G, Lamata P, Jogiya R, Kutty S, Hasenfuß G, Lotz J, Nagel E, Chiribiri A, Schuster A. Quantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility. J Cardiovasc Magn Reson 2015;17:36. [PMID: 25982348 DOI: 10.1186/s12968-015-0140-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]